Population-Based Trends in Systemic Therapy Use and Cost for Cancer Patients in the Last Year of Life | Zendy

Reka Pataky | Zendy; Winson Y. Cheung | Zendy; Claire de Oliveira | Zendy; Karen E. Bremner | Zendy; Kelvin Chan | Zendy; Jeffrey S. Hoch | Zendy; Murray Krahn | Zendy; Stuart Peacock | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Population-Based Trends in Systemic Therapy Use and Cost for Cancer Patients in the Last Year of Life

Author(s) -

Reka Pataky,

Winson Y. Cheung,

Claire de Oliveira,

Karen E. Bremner,

Kelvin Chan,

Jeffrey S. Hoch,

Murray Krahn,

Stuart Peacock

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.2946

Subject(s) - medicine , systemic therapy , cancer , population , colorectal cancer , quality of life (healthcare) , lung cancer , prostate cancer , palliative care , cancer registry , retrospective cohort study , cohort , logistic regression , breast cancer , intensive care medicine , nursing , environmental health

The use of systemic therapy near the end of life can expose cancer patients to severe toxicity for minimal survival gain and comes with a high cost. Early palliative care is recommended, but there is evidence that aggressive care remains common. To better understand those patterns, the present study set out to describe trends in systemic therapy use and cost for cancer patients in the last year of life.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research